Vivendi Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Vivendi wird ein jährliches Gewinn- und Umsatzwachstum von 31.1% bzw. 9.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 22.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 5.7% betragen.

Wichtige Informationen

31.1%

Wachstumsrate der Gewinne

22.1%

EPS-Wachstumsrate

Media Gewinnwachstum13.9%
Wachstumsrate der Einnahmen9.3%
Zukünftige Eigenkapitalrendite5.7%
Analystenabdeckung

Good

Zuletzt aktualisiert12 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Here's What Analysts Are Forecasting For Vivendi SE (EPA:VIV) After Its Interim Results

Jul 31
Here's What Analysts Are Forecasting For Vivendi SE (EPA:VIV) After Its Interim Results

Recent updates

Vivendi SE (EPA:VIV) Could Be Riskier Than It Looks

Apr 24
Vivendi SE (EPA:VIV) Could Be Riskier Than It Looks

Here's Why Vivendi (EPA:VIV) Can Manage Its Debt Responsibly

Apr 05
Here's Why Vivendi (EPA:VIV) Can Manage Its Debt Responsibly

The Strong Earnings Posted By Vivendi (EPA:VIV) Are A Good Indication Of The Strength Of The Business

Mar 15
The Strong Earnings Posted By Vivendi (EPA:VIV) Are A Good Indication Of The Strength Of The Business

When Should You Buy Vivendi SE (EPA:VIV)?

Mar 02
When Should You Buy Vivendi SE (EPA:VIV)?

Are Investors Undervaluing Vivendi SE (EPA:VIV) By 32%?

Jan 08
Are Investors Undervaluing Vivendi SE (EPA:VIV) By 32%?

Vivendi (EPA:VIV) Seems To Use Debt Quite Sensibly

Dec 14
Vivendi (EPA:VIV) Seems To Use Debt Quite Sensibly

When Should You Buy Vivendi SE (EPA:VIV)?

Nov 23
When Should You Buy Vivendi SE (EPA:VIV)?

Vivendi SE's (EPA:VIV) Intrinsic Value Is Potentially 39% Above Its Share Price

Sep 08
Vivendi SE's (EPA:VIV) Intrinsic Value Is Potentially 39% Above Its Share Price

These 4 Measures Indicate That Vivendi (EPA:VIV) Is Using Debt Reasonably Well

Aug 17
These 4 Measures Indicate That Vivendi (EPA:VIV) Is Using Debt Reasonably Well

Is It Time To Consider Buying Vivendi SE (EPA:VIV)?

Jul 30
Is It Time To Consider Buying Vivendi SE (EPA:VIV)?

Vivendi (EPA:VIV) Has A Pretty Healthy Balance Sheet

Apr 14
Vivendi (EPA:VIV) Has A Pretty Healthy Balance Sheet

Should You Think About Buying Vivendi SE (EPA:VIV) Now?

Feb 06
Should You Think About Buying Vivendi SE (EPA:VIV) Now?

Estimating The Fair Value Of Vivendi SE (EPA:VIV)

Dec 11
Estimating The Fair Value Of Vivendi SE (EPA:VIV)

At €8.34, Is It Time To Put Vivendi SE (EPA:VIV) On Your Watch List?

Oct 28
At €8.34, Is It Time To Put Vivendi SE (EPA:VIV) On Your Watch List?

These 4 Measures Indicate That Vivendi (EPA:VIV) Is Using Debt Reasonably Well

Sep 15
These 4 Measures Indicate That Vivendi (EPA:VIV) Is Using Debt Reasonably Well

Estimating The Intrinsic Value Of Vivendi SE (EPA:VIV)

Aug 25
Estimating The Intrinsic Value Of Vivendi SE (EPA:VIV)

Is Now An Opportune Moment To Examine Vivendi SE (EPA:VIV)?

Jul 14
Is Now An Opportune Moment To Examine Vivendi SE (EPA:VIV)?

We Think Vivendi (EPA:VIV) Can Manage Its Debt With Ease

May 27
We Think Vivendi (EPA:VIV) Can Manage Its Debt With Ease

Should You Investigate Vivendi SE (EPA:VIV) At €10.75?

Mar 07
Should You Investigate Vivendi SE (EPA:VIV) At €10.75?

Vivendi (EPA:VIV) Has A Pretty Healthy Balance Sheet

Dec 02
Vivendi (EPA:VIV) Has A Pretty Healthy Balance Sheet

What Does Vivendi SE's (EPA:VIV) Share Price Indicate?

Nov 11
What Does Vivendi SE's (EPA:VIV) Share Price Indicate?

Calculating The Fair Value Of Vivendi SE (EPA:VIV)

Oct 01
Calculating The Fair Value Of Vivendi SE (EPA:VIV)

Vivendi (EPA:VIV) Seems To Use Debt Quite Sensibly

Aug 18
Vivendi (EPA:VIV) Seems To Use Debt Quite Sensibly

Here's What Analysts Are Forecasting For Vivendi SE (EPA:VIV) After Its Interim Results

Jul 31
Here's What Analysts Are Forecasting For Vivendi SE (EPA:VIV) After Its Interim Results

Here's Why Vivendi SE's (EPA:VIV) CEO Might See A Pay Rise Soon

Jun 16
Here's Why Vivendi SE's (EPA:VIV) CEO Might See A Pay Rise Soon

An Intrinsic Calculation For Vivendi SE (EPA:VIV) Suggests It's 39% Undervalued

Jun 11
An Intrinsic Calculation For Vivendi SE (EPA:VIV) Suggests It's 39% Undervalued

Does Vivendi (EPA:VIV) Have A Healthy Balance Sheet?

May 12
Does Vivendi (EPA:VIV) Have A Healthy Balance Sheet?

Investors Will Want Vivendi's (EPA:VIV) Growth In ROCE To Persist

Apr 06
Investors Will Want Vivendi's (EPA:VIV) Growth In ROCE To Persist

Here's What You Should Know About Vivendi SE's (EPA:VIV) 2.1% Dividend Yield

Mar 19
Here's What You Should Know About Vivendi SE's (EPA:VIV) 2.1% Dividend Yield

Here's What Vivendi SA's (EPA:VIV) Shareholder Ownership Structure Looks Like

Mar 04
Here's What Vivendi SA's (EPA:VIV) Shareholder Ownership Structure Looks Like

Gewinn- und Umsatzwachstumsprognosen

ENXTPA:VIV - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/202619,7179649461,8995
12/31/202519,2727938651,7906
12/31/202418,7116447821,6697
6/30/202414,8643898391,337N/A
3/31/202412,6874136861,137N/A
12/31/202310,510437532937N/A
9/30/202310,137-282314716N/A
6/30/20239,764-1,00295494N/A
3/31/20239,680-857213605N/A
12/31/20229,595-712330715N/A
9/30/20229,224-440603994N/A
6/30/20228,852-1698761,272N/A
3/31/20228,785-3991,0381,455N/A
12/31/20218,717-6301,1991,637N/A
6/30/20215,486-6528561,230N/A
3/31/20217,077-2918551,228N/A
12/31/20208,668698531,226N/A
9/30/202016,1061,6301,2151,648N/A
6/30/202016,1211,8201,6422,069N/A
3/31/202016,0101,7021,2491,669N/A
12/31/201915,8981,5838551,268N/A
9/30/201915,3541,0337331,132N/A
6/30/201914,809482610996N/A
3/31/201914,3713057231,092N/A
1/1/201913,9321278361,187N/A
10/1/201814,0769631,2621,612N/A
6/30/201813,5321,2051,0811,386N/A
3/31/201813,0931,198N/A1,923N/A
1/1/201812,5181,216N/A1,690N/A
9/30/201711,753458N/A987N/A
6/30/201711,237499N/A987N/A
3/31/201710,991474N/A427N/A
12/31/201610,8191,236N/A658N/A
9/30/201610,8591,322N/A774N/A
6/30/201610,711900N/A622N/A
3/31/201610,7611,546N/A282N/A
12/31/201510,762699N/A240N/A
9/30/201510,586-114N/A758N/A
6/30/201510,478353N/A1,630N/A
3/31/201510,264-264N/A2,755N/A
12/31/201410,089-290N/A3,593N/A
9/30/201410,077162N/A4,106N/A
6/30/201410,097-116N/A4,460N/A
3/31/20149,743-49N/A4,755N/A
12/31/201310,25243N/A5,240N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: VIVDas prognostizierte Gewinnwachstum (31.1% pro Jahr) liegt über der Sparquote (1.4%).

Ertrag vs. Markt: VIVDie Erträge des Unternehmens (31.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt French (12.5% pro Jahr).

Hohe Wachstumserträge: VIVEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: VIVDie Einnahmen des Unternehmens (9.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt French (5.6% pro Jahr).

Hohe Wachstumseinnahmen: VIVDie Einnahmen des Unternehmens (9.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: VIVDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (5.7%).


Wachstumsunternehmen entdecken